Nathan B. Fountain's most recent trade in Acumen Pharmaceuticals Inc was a trade of 6,400 Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acumen Pharma Inc | Nathan B. Fountain | Director | Sale of securities on an exchange or to another person at price $ 2.23 per share. | 09 Jun 2026 | 6,400 | 48,150 | - | 2.2 | 14,273 | Common Stock |
| Acumen Pharma Inc | Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,250 | 53,250 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,500 | 54,550 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 12,800 | 19,050 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) |